Incorporating Postprandial and Fasting Plasma Glucose into Clinical Management Strategies
Bruce W. Bode, MD

Clinicians have traditionally relied on fasting plasma glucose (FPG) levels for the diagnosis of type 1 and type 2 diabetes mellitus (DM) and as a target for therapy; however, the contribution of postprandial glucose to glycosylated hemoglobin (A1C) levels is now considered.

This continuing medical education article examines the contributions of both FPG and PPG to A1C levels in patients with type 2 DM and discusses the impact of these findings on insulin treatment strategies for patients who fail to achieve recommended A1C goals.

CME Credit for this activity expired January 31, 2010.